Bellevue Life Sciences Acquisition (Bellevue Life Sciences Acquisition) EV-to-EBITDA : -32.99 (As of Apr. 29, 2024)

Bellevue Life Sciences Acquisition EV-to-EBITDA Chart

Bellevue Life Sciences Acquisition Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial						-	-291.08	-156.93	-96.04	-32.24

Competitive Comparison of Bellevue Life Sciences Acquisition's EV-to-EBITDA

For the Shell Companies subindustry, Bellevue Life Sciences Acquisition's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bellevue Life Sciences Acquisition's EV-to-EBITDA Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Bellevue Life Sciences Acquisition's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Bellevue Life Sciences Acquisition's EV-to-EBITDA falls into.

Bellevue Life Sciences Acquisition EV-to-EBITDA Calculation

Bellevue Life Sciences Acquisition's EV-to-EBITDA for today is calculated as:

Bellevue Life Sciences Acquisition's current Enterprise Value is $60.36 Mil.
Bellevue Life Sciences Acquisition's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.83 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bellevue Life Sciences Acquisition  (NAS:BLAC) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Bellevue Life Sciences Acquisition's PE Ratio for today is calculated as:

Bellevue Life Sciences Acquisition's share price for today is $10.73.
Bellevue Life Sciences Acquisition's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.050.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Bellevue Life Sciences Acquisition EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Bellevue Life Sciences Acquisition's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Bellevue Life Sciences Acquisition (Bellevue Life Sciences Acquisition) Business Description